Generic Drugs market in Japan to grow at a CAGR of 8.16% over the period 2014-2019, finds new report

A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded drugs. Generic drugs enter the market once the patent protection of the original developer expires. Generally, the cost of generic drugs is 50-70 percent lower than that of their brand-name counterparts, while meeting the very same standards of safety, quality, and efficacy as the innovator drugs. Generic drugs help the manufacturer by eliminating the need to develop and market a new drug. As the patent approaches expiration, manufacturers can apply to the FDA for approval to manufacture and sell generic versions of the drug. Generic drugs are equal to and within the bioequivalence range of branded drugs.

Report forecast the Generic Drugs market in Japan to grow at a CAGR of 8.16 percent over the period 2014-2019.

The Generic Drugs market in Japan can be divided into three segments: Generic Prescription Medicines, Super Generics, and Biosimilars. This report covers the present scenario and the growth prospects of the Generic Drugs market in Japan for the period 2015–2019. To calculate the market size, the report considers the revenue generated from the following segments:

• Generic Prescription Medicines
• Super Generics
• Biosimilars

The Generic Drugs market in Japan 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the Generic Drugs market in Japan and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Vendors

• Meiji Seika Pharma
• Nichi-Iko Pharmaceutical
• Nipro Pharma
• Sawai Pharmaceuticals
• Teva Pharmaceutical Industries
• Towa Pharmaceutical

Other Prominent Vendors

• Actavis
• Daiichi Sankyo
• Daito Pharmaceutical
• Eisai
• Fuji Pharma
• GlaxoSmithKline
• Hikari Pharmaceutical
• Hospira
• Mylan
• Nihon Generic
• Nippon Chemipher
• Nippon Kayaku
• Nissin Pharmaceutical
• Ohara Pharmaceutical
• Pfizer
• Sandoz
• Taiyo Yakuhin
• Takeda Pharmaceutical
• Zensei Pharmaceutical Industries

Market Driver

• Increase in Number of Patent Expiries
• For a full, detailed list, view our report.

Market Challenge

• Intense Competition among Vendors
• For a full, detailed list, view our report

Market Trend

• Increase in M&A
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 94 pages, “Generic Drugs Market in Japan 2015-2019” report covering the Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Country Overview of Japan, Approval Pathway of Generic Drugs in Japan, Market Landscape, Market Segmentation by Product Category, Market Segmentation by Therapeutic Application, Buying Criteria, Market Growth Drivers, Drivers and their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and their Impact, Vendor Landscape, Key Vendor Analysis. The report covered companies are – Meiji Seika Pharma, Nichi-Iko Pharmaceutical, Nipro Pharma, Sawai Pharmaceuticals, Teva Pharmaceutical Industries, Towa Pharmaceutical, Actavis, Daiichi Sankyo, Daito Pharmaceutical, Eisai, Fuji Pharma, GlaxoSmithKline, Hikari Pharmaceutical,Hospira, Mylan, Nihon Generic, Nippon Chemipher, Nippon Kayaku, Nissin Pharmaceutical, Ohara Pharmaceutical, Pfizer, Sandoz, Taiyo Yakuhin, Takeda Pharmaceutical, Zensei Pharmaceutical Industries

For further information on this report, please visit- http://mrr.cm/4Sf

Find all Healthcare Reports at: http://www.marketresearchreports.com/healthcare